Anna Pawlowska
Pediatric Hematology-Oncology · Duarte, CANPI 1023125804
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 30.0% of the total. Reporting peaked in 2022 at $340 and has fallen 87.6% since, to $42 in 2024. That places this record below the midpoint for pediatric hematology-oncology clinicians in CA, where the typical reported total is $536.
Across 15 payments — averaging $50.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$226
- Eurofins Viracor, LLC$175
- Janssen Scientific Affairs, LLC$135
- AstraZeneca$86
- Stemline Therapeutics Inc.$61
- Merck$25
- plus $43 from 2 others
Across 20 payments — averaging $18,932 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$166K
- Jazz Pharmaceuticals Inc.$133K
- Bristol Myers Squibb$45K
- E.r. Squibb & Sons, L.L.C.$28K
- National Marrow Donor Program$6K
What the payments were for
- Food & beverage$751100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 5 | $226 |
| Eurofins Viracor, LLC | 1 | $175 |
| Janssen Scientific Affairs, LLC | 1 | $135 |
| AstraZeneca | 4 | $86 |
| Stemline Therapeutics Inc. | 1 | $61 |
| Merck | 1 | $25 |
| Vertex | 1 | $24 |
| Seagen Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$751 in reported general payments places this provider in the 50th percentile of 307 pediatric hematology-oncology providers in California.
See all pediatric hematology-oncology providers in California →
Other pediatric hematology-oncology in Duarte
- Joseph RosenthalDuarte$39K
- Lindsey MurphyDuarte$31K
- Philip PizzoPalo Alto$2.6M
- Vinod BalasaMadera$508K
- Akshat JainRedlands$447K
- Noah FedermanLos Angeles$399K
- Vanessa Salinas-LunaOrange$344K
- Daniel KraftStanford$294K
- Arash MahajerinOrange$249K
- Elysia AlvarezPalo Alto$200K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.